↓ Skip to main content

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer

Overview of attention for article published in Frontiers in oncology, March 2021
Altmetric Badge

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
Published in
Frontiers in oncology, March 2021
DOI 10.3389/fonc.2021.632657
Pubmed ID
Authors

Sungpil Yoon, Xiaoju Wang, Sompong Vongpunsawad, Gerard Tromp, Helena Kuivaniemi

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 33%
Professor > Associate Professor 1 17%
Librarian 1 17%
Unknown 2 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 33%
Medicine and Dentistry 1 17%
Unknown 3 50%